Literature DB >> 1514917

Splenopneumopexy to treat portal hypertension produced by venous occlusive disease.

J C Reese1, R B Fairchild, J J Brems, D L Kaminski.   

Abstract

Splenopneumopexy is intended to induce collateral circulation between the portal system and the pulmonary veins. It involves performing a parenchymatous anastomosis between the amputated superior pole of the spleen and the exposed pulmonary venous structures in the left lower lobe. This operative procedure was used to treat four patients with extended portal-splenic-mesenteric venous occlusion who did not respond satisfactorily to sclerotherapy. The patients underwent transfemoral embolization of their splenic arteries before splenopneumopexy. Following the operations, all patients have remained well, experiencing cessation of gastrointestinal bleeding for up to 48 months. Splenopneumopexy may be a therapeutic alternative in selected patients with portal hypertension, including those patients with widespread occlusion of the portal vein and its radicles.

Entities:  

Mesh:

Year:  1992        PMID: 1514917     DOI: 10.1001/archsurg.1992.01420090141021

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

1.  Splenopneumopexy: decompression of portal hypertension in the setting of portal venous occlusive disease.

Authors:  Jeffrey M Sutton; Michael S Nussbaum; Doan Vu; Tayyab S Diwan; Sandra L Starnes; Shimul A Shah
Journal:  Dig Dis Sci       Date:  2014-10-30       Impact factor: 3.199

Review 2.  The Surgical Treatment of Portal Hypertension.

Authors:  J Michael Henderson; Christopher D Anderson
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

3.  Massive Gastric Bleed 20 Years After Splenopneumopexy.

Authors:  Ahmad Abulawi; Ali H Al-Tarbsheh; Rosa Bui; Seth Richter
Journal:  ACG Case Rep J       Date:  2022-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.